{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:54:07Z","timestamp":1791550447757,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amjmed.2026.08.032","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:19:21Z","timestamp":1789665561000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gaps in receipt of alcohol treatment services among adults with hepatic steatosis"],"prefix":"10.1016","author":[{"given":"Robert J","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meimei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Ostacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L","family":"Batki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek D","family":"Satre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsey","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2026.08.032_bib0001","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","article-title":"National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0002","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","article-title":"Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020","volume":"22","author":"Kalligeros","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0003","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0004","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0005","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0006","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2025.100804","article-title":"Estimating steatotic liver disease prevalence among US veterans","volume":"4","author":"Wong","year":"2025","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0008","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0009","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsat.2018.05.003","article-title":"Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis","volume":"91","author":"Mellinger","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0010","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000093","article-title":"Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis","volume":"7","author":"Rabiee","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0011","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.31042","article-title":"Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis","volume":"71","author":"Rogal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0012","article-title":"Barriers and facilitators of alcohol use disorder treatment for alcohol-associated liver disease: a systematic review","author":"Kim","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0013","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/acer.15500","article-title":"Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrhosis","volume":"49","author":"Luk","year":"2025","journal-title":"Alcohol Clin Exp Res (Hob)"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0014","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamasurg.2024.4518","article-title":"Risk factors for metabolic disease in veterans: beyond BMI","volume":"160","author":"Lu","year":"2025","journal-title":"JAMA Surg"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0015","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.amjmed.2023.11.013","article-title":"Alcohol use patterns during and after the COVID-19 pandemic among veterans in the United States","volume":"137","author":"Wong","year":"2024","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0016","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol use disorders Identification test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0017","first-page":"597","article-title":"Implementation of evidence-based alcohol screening in the Veterans Health Administration","volume":"12","author":"Bradley","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0018","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archinte.163.7.821","article-title":"Two brief alcohol-screening tests from the Alcohol Use Disorders Identification Test (AUDIT): validation in a female veterans affairs patient population","volume":"163","author":"Bradley","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0019","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/HEP.0000000000000843","article-title":"AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0020","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/acer.12107","article-title":"Predictors of initial and sustained remission from alcohol use disorders: findings from the 30-year follow-up of the San Diego Prospective Study","volume":"37","author":"Trim","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0021","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jhep.2025.05.030","article-title":"Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification","volume":"83","author":"Tavaglione","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0022","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S2468-1253(25)00187-6","article-title":"Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study","volume":"10","author":"Torp","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0023","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1053\/j.gastro.2024.02.032","article-title":"Impact of longitudinal alcohol use patterns on long-term risk of cirrhosis among US veterans with steatotic liver disease","volume":"166","author":"Wong","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0024","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jhep.2024.06.036","article-title":"Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease","volume":"81","author":"Marti-Aguado","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0025","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamainternmed.2025.1809","article-title":"Adverse liver outcomes, cardiovascular events, and mortality in steatotic liver disease","volume":"185","author":"Ochoa-Allemant","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.47548","article-title":"Alcohol intake thresholds among individuals with steatotic liver disease","volume":"6","author":"Yeo","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0027","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S2468-1253(25)00193-1","article-title":"Reducing alcohol-associated liver disease burden in the general population","volume":"10","author":"Asrani","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0028","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0029","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(23)00157-7","article-title":"Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis","volume":"8","author":"Huang","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.08.032_bib0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.13014","article-title":"Incidence and progression of alcohol-associated liver disease after medical therapy for alcohol use disorder","volume":"5","author":"Vannier","year":"2022","journal-title":"JAMA Netw Open"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326006662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326006662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:27:09Z","timestamp":1791548829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934326006662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0002934326006662"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.08.032","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaps in receipt of alcohol treatment services among adults with hepatic steatosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}